Skip to main content

Animations

MJFF Publications

1691 - 1700 of 8808 Results
Title
Year
  • Year
  • 2016
  • 2010
  • 2008
  • 2009
  • 2009
  • 2016
  • 2010
  • 2013
  • 2010
  • 2014
  • Summary Details
    OPEN
    Title: Ser(P)‐1292 LRRK2 in urinary exosomes is elevated in idiopathic Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26686
    Citation Count: 181
  • Summary Details
    OPEN
    Title: Chronic deprivation of TrkB signaling leads to selective late-onset nigrostriatal dopaminergic degeneration
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2010.12.018
    Citation Count: 75
  • Summary Details
    OPEN
    Title: Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.21425
    Citation Count: 719
  • Summary Details
    OPEN
    Title: Dopamine D3 receptor selective ligands with varying intrinsic efficacies at adenylyl cyclase inhibition and mitogenic signaling pathways
    Journal Name: Synapse
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/syn.20725
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Conditional transgenic mice expressing C-terminally truncated human α-synuclein (αSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/1750-1326-4-34
    Citation Count: 90
  • Summary Details
    OPEN
    Title: Oxidation and interaction of DJ-1 with 20S proteasome in the erythrocytes of early stage Parkinson’s disease patients
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/srep30793
    Citation Count: 34
  • Summary Details
    OPEN
    Title: A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions
    Journal Name: Molecular and Cellular Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.mcn.2010.12.011
    Citation Count: 72
  • Summary Details
    OPEN
    Title: Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutations
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.25647
    Citation Count: 136
  • Summary Details
    OPEN
    Title: α-Synuclein Gene May Interact with Environmental Factors in Increasing Risk of Parkinson’s Disease
    Journal Name: Neuroepidemiology
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1159/000315157
    Citation Count: 62
  • Summary Details
    OPEN
    Title: Abrogation of α-synuclein–mediated dopaminergic neurodegeneration in LRRK2-deficient rats
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1403215111
    Citation Count: 206
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.